Search

everythinglearnresearchcommunity

for

Search:↓

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Genetics and hormones cause hair loss; finasteride treats it safely.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Laser laparoscopy effectively reduces pelvic pain in women with mild to moderate endometriosis and is safe to use.

The new method showed that endometriotic tissue has lower estrogen receptor levels but similar progesterone levels compared to normal endometrium, with both following a similar cycle.

Hysteroscopic surgery is better than hysterectomy for treating dysfunctional uterine bleeding due to fewer complications and quicker recovery, with high satisfaction in both treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.